Trastuzumab 180288-69-1
2 Inquiries
180288-69-1
98%
Beijing
1G/bottle
2026-05-13
API,Pembrolizumab,semaglutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionHerceptin (generic name: trastuzumab) is not a chemo drug, it is a targeted therapy anticancer drug.Herceptin contains one active ingredient, trastuzumab, and is given as an intravenous (IV) infusion slowly into a vein. Herceptin Hylecta contains two active ingredients, trastuzumab and hyaluronidase-oysk, and is given as a subcutaneous injection, which is an injection that goes under the skin.Basic Info
-
Product Name:
Trastuzumab
Other Name:Herceptin;TrastuzuMab(Herceptin);TRASTUZUMAB 98 % +;IMMunoglobulin G1,anti-(huMan p185neu receptor) (huMan-Mouse Monoclonal rhuMab HER2 g1-chain), disulfide with huMan-MouseMonoclonal rhuMab HER2 light chain, diMer;TRASTUZUMAB 95 % +;Anti HER2, Ig gamma-1 chain C region;Recombinant humanized anti-HER2 antibody;RhuMab HER2
CAS No.:180288-69-1
Molecular Formula:C10H14N6O5
InChIKeys:FNXPTCITVCRFRK-MIUWUGMQNA-N
Molecular Weight:298.25536
Color/Form:White to light yellow
Categories:
Characteristics-
Critical Temperature & Pressure:
Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
API,Pembrolizumab,semaglutide
-
Location:
NO. 5435, ROOM 05, FLOOR 5, BUILDING 23, TENGFEI SCIENCE PARK, NO.388 XINPING STREET, SUZHOU INDUSTRIAL PARK, CHINA Pilot Free Trade Zone, Suzhou
-
Payment Terms:
L/C,100% TT in advance
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2023
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
Philippines
Trastuzumab
10 PCS Oct 29, 2025
Philippines
Trastuzumab
10 PCS Oct 25, 2025 Post an enquiry for this product